The table below shows Zenas BioPharma, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
$0.00
$0.00
$10.00M
$0.00
$0.00
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$60.44M
$34.40M
$43.03M
$34.91M
$33.53M
$33.81M
SG&A
ZBIO annual revenue (10-K history)
Zenas BioPharma, Inc. reported annual revenue of $10.00M for fiscal year 2025. That is up 100.0% from $5.00M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.